Hydrofluoroalkane-134a Beclomethasone
... as hydrofluoroalkane-134a (HFA) has provided the opportunity to significantly improve the delivery of inhaled drugs to the respiratory tract.8,9 Beclomethasone dipropionate (BDP), an established corticosteroid for the treatment of asthma, has now been reformulated using the new HFA propellant. In c ...
... as hydrofluoroalkane-134a (HFA) has provided the opportunity to significantly improve the delivery of inhaled drugs to the respiratory tract.8,9 Beclomethasone dipropionate (BDP), an established corticosteroid for the treatment of asthma, has now been reformulated using the new HFA propellant. In c ...
College of Pharmacy/University of Baghdad
... patients on monotherapy with a β-blocker, resulting in the need for a different agent or combination therapy (3). β-Blockers can cause significant systemic adverse effects , Bronchospasm is the most common pulmonary effect of topical β-blockers. Cardiovascular effects include bradycardia, hypote ...
... patients on monotherapy with a β-blocker, resulting in the need for a different agent or combination therapy (3). β-Blockers can cause significant systemic adverse effects , Bronchospasm is the most common pulmonary effect of topical β-blockers. Cardiovascular effects include bradycardia, hypote ...
Pharmacy update What`s new in the world of pharmaceuticals?
... • Gain deeper awareness of how older medications may benefit, or harm, their patients • Understand recent changes in medication treatment approaches for common medical conditions, including diabetes, hypertension, hyperlipidemias, and infectious diseases ...
... • Gain deeper awareness of how older medications may benefit, or harm, their patients • Understand recent changes in medication treatment approaches for common medical conditions, including diabetes, hypertension, hyperlipidemias, and infectious diseases ...
Tricaine MPS
... compliance, azithromycin could become the preferred drug of choice over ceftriaxone, ofloxacin & chloramphenicol in Typhoid Fever. Sir, Half-life of Azithromycin is 68 Hrs while that of Ofloxacin is just 3-4Hrs & it works only for 9 Hrs. Azithromycin concentrates intracellularly & 50% is excreted un ...
... compliance, azithromycin could become the preferred drug of choice over ceftriaxone, ofloxacin & chloramphenicol in Typhoid Fever. Sir, Half-life of Azithromycin is 68 Hrs while that of Ofloxacin is just 3-4Hrs & it works only for 9 Hrs. Azithromycin concentrates intracellularly & 50% is excreted un ...
EFFEXOR XR INSTRUCTION SHEET EFFEXOR XR
... Partial dosing: During transition, (if less than 37.5 or between 37.5 and 75mg is needed), capsules may be opened and used as a sprinkle form on any soft food. Sprinkled granules remain slow release unless bitten into. PANIC PATIENTS NOTE: This step is especially important in panic disorder where in ...
... Partial dosing: During transition, (if less than 37.5 or between 37.5 and 75mg is needed), capsules may be opened and used as a sprinkle form on any soft food. Sprinkled granules remain slow release unless bitten into. PANIC PATIENTS NOTE: This step is especially important in panic disorder where in ...
Tarceva - Genentech
... • The treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen [see Clinical Studies (14.3)]. Limitations of use: • TARCEVA is not recommended for use in combination with platinum-based chemotherapy [see Clinical St ...
... • The treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen [see Clinical Studies (14.3)]. Limitations of use: • TARCEVA is not recommended for use in combination with platinum-based chemotherapy [see Clinical St ...
Review of vancomycin-containing medicines started Information on
... Vancomycin is a glycopeptides antibiotic and is given by infusion (drip) into a vein to treat serious infections due to Gram-positive bacteria such as meticillin-resistant Staphylococcus aureus (MRSA) that are resistant to other antibiotics, or in patients in whom other antibiotics cannot be used. ...
... Vancomycin is a glycopeptides antibiotic and is given by infusion (drip) into a vein to treat serious infections due to Gram-positive bacteria such as meticillin-resistant Staphylococcus aureus (MRSA) that are resistant to other antibiotics, or in patients in whom other antibiotics cannot be used. ...
Antifungals
... fungal cell membrane – Loss of any of the enzymes required to produce the active forms that interfere with DNA synthesis Resistance occurs frequently and rapidly when flucytosine is given as monotherapy Always use combination therapy ...
... fungal cell membrane – Loss of any of the enzymes required to produce the active forms that interfere with DNA synthesis Resistance occurs frequently and rapidly when flucytosine is given as monotherapy Always use combination therapy ...
Dr. Kelley`s PowerPoint slides
... partial-onset seizures: results of randomized global phase III study 305. Epilepsia. 2013;54:117–125. 14. Krauss GL, Serratosa JM, Villanueva V, et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology. 2012;78:1408–1415. 15. Bullman J, Nicholls A ...
... partial-onset seizures: results of randomized global phase III study 305. Epilepsia. 2013;54:117–125. 14. Krauss GL, Serratosa JM, Villanueva V, et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology. 2012;78:1408–1415. 15. Bullman J, Nicholls A ...
Product Information - Therapeutic Goods Administration
... plasma concentration (Cmax) is reached 2 to 4 hours hours after dosing. Plasma concentrations are dose-proportional up to 300 mg twice daily. After repeated administration, the steady-state is reached within 2 to 3 days. In these conditions, the Cmax is about 250 ng/mL after a 100 mg daily dose give ...
... plasma concentration (Cmax) is reached 2 to 4 hours hours after dosing. Plasma concentrations are dose-proportional up to 300 mg twice daily. After repeated administration, the steady-state is reached within 2 to 3 days. In these conditions, the Cmax is about 250 ng/mL after a 100 mg daily dose give ...
Guide for Drug Level Monitoring of Commonly Used Medications
... Vancomycin peak levels should not be obtained Obtain trough in patients with unstable renal function, renal replacement therapy, when serum Cr may not accurately reflect GFR i.e. patients > 70, reduced muscle mass, severely altered volumes of distribution, or for CNS infections, endocarditis, ventil ...
... Vancomycin peak levels should not be obtained Obtain trough in patients with unstable renal function, renal replacement therapy, when serum Cr may not accurately reflect GFR i.e. patients > 70, reduced muscle mass, severely altered volumes of distribution, or for CNS infections, endocarditis, ventil ...
Attachment: Product Information: Mirabegron
... mirabegron. After once daily administration, plasma exposure of mirabegron at steady state is approximately double that seen after a single dose. Co-administration of a 50 mg tablet with a high-fat meal reduced mirabegron Cmax and AUC by 45% and 17%, respectively. A low-fat meal decreased mirabegron ...
... mirabegron. After once daily administration, plasma exposure of mirabegron at steady state is approximately double that seen after a single dose. Co-administration of a 50 mg tablet with a high-fat meal reduced mirabegron Cmax and AUC by 45% and 17%, respectively. A low-fat meal decreased mirabegron ...
Epilepsy For Internists 2003
... • Pregnancy must be planned due to neural tube defect risk on AEDs • Many AEDs decrease levels of OCPs and therefore higher OCP dosing (40mcg estrogen) recommended for efficacy – Always recommend double contraception ...
... • Pregnancy must be planned due to neural tube defect risk on AEDs • Many AEDs decrease levels of OCPs and therefore higher OCP dosing (40mcg estrogen) recommended for efficacy – Always recommend double contraception ...
DATA SHEET Presentation Uses
... 0.3 mg/kg/day (a rodent-specific pharmacological effect; systemic exposure estimated to be at least 41 times the intended human exposure). This maternal toxicity likely resulted in decreased mating performance and gestational body weight gain in the offspring, but neurobehavioural functions were not ...
... 0.3 mg/kg/day (a rodent-specific pharmacological effect; systemic exposure estimated to be at least 41 times the intended human exposure). This maternal toxicity likely resulted in decreased mating performance and gestational body weight gain in the offspring, but neurobehavioural functions were not ...
AN OPEN STUDY TO ASSESS THE SAFETY AND TOLERABILITY
... glomerular filtration rate [19]. Consequently, NSAID intervention may cause acute intrarenal haemodynamic changes in patients whose renal blood flow is dependent on prostaglandins, and this can result inreversibleacute renal failure. Certain patients are particularly at risk of NSAID-associated rena ...
... glomerular filtration rate [19]. Consequently, NSAID intervention may cause acute intrarenal haemodynamic changes in patients whose renal blood flow is dependent on prostaglandins, and this can result inreversibleacute renal failure. Certain patients are particularly at risk of NSAID-associated rena ...
2016 MPhA MTM Symposium
... • Annual rate of moderate or severe COPD exacerbations: 0.9 vs. 1.19 [P<0.001] (17% lower rate). • Time to first moderate or severe exacerbation: 128 days vs. 87 days [P<0.001] (22% lower risk). ...
... • Annual rate of moderate or severe COPD exacerbations: 0.9 vs. 1.19 [P<0.001] (17% lower rate). • Time to first moderate or severe exacerbation: 128 days vs. 87 days [P<0.001] (22% lower risk). ...
Stevens-Johnson syndrome and toxic epidermal
... immunoglobulin (IVIG) , have been used in an attempt to halt the disease process. The use of IVIG in particular is controversial. We share our experience with the use of IVIG in six patients with TEN. We will also review the various proposed mechanisms underlying TEN, the mechanism of action of IVIG ...
... immunoglobulin (IVIG) , have been used in an attempt to halt the disease process. The use of IVIG in particular is controversial. We share our experience with the use of IVIG in six patients with TEN. We will also review the various proposed mechanisms underlying TEN, the mechanism of action of IVIG ...
renal pharmacology - ANNA Jersey North Chapter 126
... End stage renal failure is defined as the condition in which the kidneys fail to remove metabolic waste products, regulate pH, or control fluid balance. ...
... End stage renal failure is defined as the condition in which the kidneys fail to remove metabolic waste products, regulate pH, or control fluid balance. ...
New Insight in to an Old Therapy for the Treatment of Acute
... was also compared to placebo to usual diuretic therapy. Dopamine is an endogenous catecholamine that, at low doses (≤3 μg/kg/min), may selectively activate dopamine receptors and promote renal vasodilatation [16,17]. This low dose dopamine did not cause any improvement in urinary sodium excretion, w ...
... was also compared to placebo to usual diuretic therapy. Dopamine is an endogenous catecholamine that, at low doses (≤3 μg/kg/min), may selectively activate dopamine receptors and promote renal vasodilatation [16,17]. This low dose dopamine did not cause any improvement in urinary sodium excretion, w ...
ISMP Medication Safety Alert
... and proper use of the product. Use the applicator, spray set, and pressure control device or regulator as noted in the labeling. Use an airor gas-pressure setting within the range recommended by the manufacturer. Ensure that the distance between the spray head and the tissue is at or above the minim ...
... and proper use of the product. Use the applicator, spray set, and pressure control device or regulator as noted in the labeling. Use an airor gas-pressure setting within the range recommended by the manufacturer. Ensure that the distance between the spray head and the tissue is at or above the minim ...
1400_Milligan_GF5E3
... Klein, Jeffrey A. (1990). Tumescent Technique for Regional Anesthesia Permits Lidocaine Doses of 35 mg/kg for Liposuction. J. Dermatol Surg Oncol 1990; 16:248-263. Retrieved from http://tumescent.org/tumescenttechnique-for-regional-anesthesia-permits-lidocaine-doses-of-35-mgkg-for-liposuction/ ...
... Klein, Jeffrey A. (1990). Tumescent Technique for Regional Anesthesia Permits Lidocaine Doses of 35 mg/kg for Liposuction. J. Dermatol Surg Oncol 1990; 16:248-263. Retrieved from http://tumescent.org/tumescenttechnique-for-regional-anesthesia-permits-lidocaine-doses-of-35-mgkg-for-liposuction/ ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... end of prophylaxis, the incidence of acute gout attacks requiring treatment was higher in patients with lower sUA levels, probably reflecting continued mobilization of pre-existing urate crystals and implying that a longer period of prophylaxis was required. The study which included a small subset o ...
... end of prophylaxis, the incidence of acute gout attacks requiring treatment was higher in patients with lower sUA levels, probably reflecting continued mobilization of pre-existing urate crystals and implying that a longer period of prophylaxis was required. The study which included a small subset o ...
BMS Data Update - UK-CAB
... 903E Study: Investigators’ Conclusions Through 7 years of therapy in antiretroviral-naïve patients, TDF + 3TC+ EFV demonstrated the following: • Sustained, durable antiretroviral efficacy ...
... 903E Study: Investigators’ Conclusions Through 7 years of therapy in antiretroviral-naïve patients, TDF + 3TC+ EFV demonstrated the following: • Sustained, durable antiretroviral efficacy ...
How do you spell that?
... • Diarrhea (20%) and flatulence (5%) most common adverse effects; 5% of treatment arm stopped meds due to diarrhea ...
... • Diarrhea (20%) and flatulence (5%) most common adverse effects; 5% of treatment arm stopped meds due to diarrhea ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.